The preparation of a reagent which can be used to attach biotin to proteins via a cleavable connector arm is described. The reagent, 3-(4-(N-biotinoyl-6-aminocaproyloxy)phenyl)propionic acid N-hydroxysuccinimide ester (BPE), can acylate amino groups of proteins and other compounds via reaction of the N-hydroxysuccinimide ester function. Compounds which have been covalently labeled with BPE can be selectively retrieved (at physiological pH values) from complex mixtures by adsorbing the target compounds on immobilized avidin. These compounds can be released from the avidin by cleavage of the phenyl ester linkage of the connector arm under conditions which don't denature proteins. Insulin was labeled with BPE. The binding of the labeled insulin to immobilized avidin, and its subsequent release by treatment at room temperature with 1 M hydroxylamine at pH 7 was demonstrated.
The highly specific and very strong binding of biotin to avidin (KD -lo-l5 M; (7)) could provide us with a basis for the design of elegant protocols for the retrieval of compounds from cells and physiological fluids even when the compounds targeted for retrieval are present at very low concentrations.
For example, a polypeptide hormone that had been covalently labeled with biotin could be incubated with cells and later retrieved by adsorption on immobilized avidin for studies of hormone catabolism and for isolation of hormonereceptor complexes. Unfortunately, the direct application of this approach is usually precluded by the very low rate constant for the dissociation of biotin from ' Financial support for this work from National Institutes of Health Grant AM 27659 is gratefully acknowledged.
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avidin (ti,z -200 days; (7)), and the fact that all of the methods which are known to increase the rate of decomposition of the avidin:biotin complex lead to irreversible protein denaturation.
This difficulty has been overcome to some extent by the use of 2-iminobiotin (8, 10) . Unlike biotin, 2-iminobiotin interacts with avidin very poorly at low pH values. Thus, proteins labeled with 2-iminobiotin can be eluted from immobilized avidin at pH 4. There are two limitations associated with the use of 2-iminobiotin, however. One is that the pH must be above 9.5 for immobilized avidin to exhibit significant adsorption of 2-iminobiotin-labeled proteins from dilute solutions (10) . The other is that avidin binds 2-iminobiotin much less tightly than biotin. For example, the relative affinity of biotin and 2-iminobiotin for avidin is 2.8 X 10' at pH 9.5 and 3.5 X 104 at pH values well above 12 where 2-iminobiotin (pK, 11.9) exists primarily in its basic form. These considerations suggest that a biotin label might be more useful than a 24minobiotin label for specific retrieval solution or are present at very low conof proteins and macromolecular complexes centrations (or both). In this work we deof proteins which are unstable in alkaline scribe the preparation of a biotin derivative (BPE)4 which can be used to link bio- BPE tin to polypeptides and other compounds via a cleavable connector arm. After the biotinoylated compound has been adsorbed on immobilized avidin under physiological conditions, it can be selectively released from the avidin by breaking the phenyl ester linkage in the connector arm. The cleavable phenyl ester linkage contained in BPE has an advantage over other cleavable linkages commonly used in crosslinking agents, in that it can be broken under mild conditions which do not result in reduction of disulfide bonds or oxidation of glycosyl residues.
MATERIALS AND METHODS
N-Hydroxysuccinimide (NHS) obtained from Aldrich Chemical Company was recrystallized from ethyl acetate. Dimethyl sulfoxide (Me#O) was dried over a molecular sieve and trifluoroacetic acid (Aldrich Chemical Co.) was distilled. Triethylamine, dimethylformamide (DMF), isopropanol, and dioxane were distilled from phthalic anhydride, PzOs, CazS04, and LiAIHI, respectively. Ben& 8-(.&-h~droxgph.tm~l)pr@mate (I). 3-(4-Hydroxyphenyl)propionic acid (HPPA), 50 g (0.3 mol) as obtained from Aldrich Chemical Company, was converted to the monopotassium salt by dissolving it in 300 ml of 1 N KOH, and removing the water under reduced pressure. The monopotassium salt of HPPA was dissolved in 400 ml of warm 95% ethanol in a round-bottom flask equipped with a reflux condenser. The solution was heated to reflux, and benzyl bromide (32.5 ml, 0.273 mol) in 100 ml of ethanol was added over 1 h with stirring. The reaction mixture was heated under reflux for another 1.5 h, whereupon it was cooled, and the ethanol removed under reduced pressure. The resulting oil was suspended in 1.5 liters of HzO, neutralized to pH '7 with NaHCOa, and stirred for 0.5 h. The aqueous suspension was then extracted three times with ether, and the combined ether extract, was back-extracted with 0.02 N sodium phosphate buffer (pH 7). After the ether extract was dried over sodium sulfate, the ether was removed under reduced pressure, and the resulting oil was distilled under reduced pressure. The fraction which boiled at 170-174"C, 0.03 mm Hg, was collected to yield 46.8 g (68%) of the desired product, an oil (d = 1.179) NMR (60 MHz CDCla + 1% TMS) 8 7.28 (5H, s, ArH), 6 6.92 (4H, m, ArH), 6 5.09 (2H, s. ArCHzO), 6 2.72 (4H, m, CHz). The product exhibited a change in molar absorptivity accompanying neutralization (with KOH) of the phenolic hydroxyl group which was within 3% of that seen for HPPA (AC% 2540 cm-' M-' in 20% ethanol-water).
N-Benz&rxycnrbwql-6-aminocaproic acid (II). Benzyl chloroformate (48 ml, 0.34 mol) was added slowly (over 1 h) to a vigorously stirred solution of 6-aminocaproic acid (40 g, 0.31 mol) in 38 ml of 4 N NaOH which was cooled in an ice bath, and maintained at pH 9.5-10.5 by addition of 4 N NaOH. After addition of the benzyl chloroformate, the solution was stirred for another 5 min, extracted three times ' Abbreviations used: B-insulin, the derivatives of insulin produced upon modification of insulin and tracer amounts of peaI]insulin with excess biotin Nhydroxysuccinimide ester; BPE, 3-(4-(biotinoyl-6-aminocaproyloxy)phenyl)propionic acid N-hydroxysuccinimide ester; BPE-insulin, the derivatives of insulin produced upon modification of insulin and tracer amounts of $-(4-(6-Aminocaproylp~yl)propionic acid hydrobromide (IV). Crude III (2.49g containing 2.92 mmol phenyl ester) and anisole (1 ml, 9.2 mmol) were mixed with 9 ml of trifluoroacetic acid, and HBr (g) was bubbled through the reaction mixture. After 1.75 h, (which was found to be the optimum reaction time), the reaction mixture was poured with stirring into 300 ml of ether. The optimum reaction time for removal of the benzyl and benzyloxycarbonyl groups was indicated by the formation of a precipitate approximately 5 min after 50 ~1 of the reaction mixture had been added to 1 ml of ether. Extended reaction times resulted in decomposition of the desired reaction product.
After the reaction mixture had been stirred with the ether for 20 min, the resulting solid was collected, dissolved in ethanol, and precipitated with ether repeatedly to yield 0.46 g (44%) of IV mp 160-161°C. Biotin N-hydroxysuccinimide ester (V). This compound was synthesized using a procedure similar to that of May et al (9) is the observed initial absorbance of VII in the ab-sence of imidazole. The standard deviation for this analysis was less than 3%. General gperations used with avidin Sepharose. Gels were treated with solutions at room temperature for the indicated times by shaking the mixtures on a Burrell wrist-action shaker or by stirring them on a magnetic stirrer. Both mixing procedures gave similar results. The reaction vessel was a 75 X 12 (o.d.)-mm glass test tube, which could be used as a sample container in the gamma counter (Searle Analytic Inc., Model 1130) for determinations of radioactive material in the gel phase. Gels were washed by treating them for 1 min with the specified wash solution. Solutions were separated from gels by centrifugation on an International Clinical desk top centrifuge. Prior to determination of their radioactivity aliquots of the supernatant solutions were subjected to a second centrifugation in a Beckman microfuge to ensure removal of trace amounts of gel.
Rem&m of insulin derivatives with awidin Sepharose. Avidin Sepharose (0.1 ml) was suspended in 0.5 ml of 0.1 M sodium phosphate buffer, 0.1% BSA (pH 7.0) and treated for 4 h with the indicated amounts of BPE-insulin or B-insulin. The unbound insulin derivative was removed by centrifugation and the gel was washed three times with 1 ml of 0.1 M phosphate buffer, 1 mg/ml BSA (pH 7.0) and once by treating the gel for 40 min with 1 ml of a buffer consisting of 0.1 M phosphate, 1 M NaCl, 1 mg/ml BSA (pH 7.0). The radioactivity of the washes was monitored as well as the radioactivity of the washed gel. The last wash contained less than 2% of the radioactivity of that which was present in the washed gel.
Cleavage of phenyl ester linkages and release of gelbound insulin This was accomplished by treating 0.1 ml gel for 40 min with 1 ml of 1.0 M NHzOH, 1 mg/ ml BSA (pH 7.0). The hydroxylamine solution was prepared by addition of BSA to NHzOHHCl which had been neutralized with NaOH to pH 7.0, and adjusted to 1 M NHzOH. After reaction with NHzOH the gel was washed three times with 1 ml of 0.1 M phosphate buffer, 1 mg/ml BSA (pH 7.0). The release of radioactive insulin derivative from the gel was monitored by determination of the radioactivity in the gel and liquid phases.
The biotin binding capacity of avidin Sephmose. This was determined by treating a l.O-ml aliquot of avidin Sepharose suspension for 1 h with 50 pl of a solution containing a known concentration of biotin in water. The amount of biotin which bound to the gel was determined from the difference between the amount of biotin added and the amount of unbound biotin in the supernatant solution obtained after removal of the gel by centrifugation. The amount of biotin in the supernatant solution was determined in a manner similar to that described for the determination of the biotin content of organic compounds.
Biotin standards in the same buffer as the gel supernatant solution were used to calibrate the assay.
RESULTS AND DISCUSSION
Reaction of BPE with insulin resulted in covalent attachment of biotin to insulin as evidenced by the behavior of the resultant BPE-insulin toward avidin Sepharose (see below). The reaction of BPE with insulin should be analogous to that reported for the reaction of biotin N-hydroxysuccinimide ester (V) with insulin wherein Nhydroxysuccinimide is displaced from V by the amino groups of insulin with concomitant formation of amide bonds (9) . The biotin in the insulin derivative of V (B-insulin), however, is linked to the insulin via a noncleavable linkage, whereas in BPE-insulin the biotin is attached to the insulin via a cleavable connector arm. Since there are three amino groups in insulin, seven derivatives can result from the reaction of insulin with BPE or V.5 In the procedure used in this work to label insulin with BPE or V, a greater than ninefold molar excess of BPE or V was reacted with insulin for 5.5 h to ensure that essentially all of the insulin molecules would be covalently linked to at least one biotin group.6 Furthermore, the insulin was reacted in the presence of tracer amounts of ['251]insulin to facilitate quantification of the binding of the resulting BPE-insulin or B-insulin to immobilized avidin (avidin-Sepharose).
The titrations 5 The seven insulin derivatives of V and BPE have been separated by HPLC. The preparation and physiological properties of these derivatives will be described elsewhere.
6 The derivitized insulins used here are primarily trisubstituted with biotin. To obtain the other BPEinsulin derivatives, a mixture of the seven derivatives was prepared by reaction of a ninefold molar excess of BPE with 2 mg/ml insulin in a solution composed of equal volumes of acetonitrile and 0.2~ sodium phosphate buffer (pH 6.6 before mixing). After 45 min the reaction mixture was quenched by addition of 0.1 volume of 2 M phosphoric acid. The seven BPEinsulin derivatives were isolated from each other and unreacted insulin by HPLC on a C-8 column using an acetonitrile-sodium phosphate (pH 3.1) gradient as eluent. of avidin Sepharose depicted in Fig. 1 yield binding capacities of 11 nmol B-insulin and 8.9 nmmol BPE-insulin per milliliter of avidin Sepharose. Separate determinations of the capacity of the gel to bind free biotin indicated that the avidin Sepharose could bind 31 nmol of biotin per milliliter of gel. The approximately threefold lower binding capacity observed with BPE-insulin and B-insulin may well reflect, in part, the ability of the polyvalent biotinoylated insulin derivatives to fill more than one biotin binding site. Limited access of the insulin derivatives to the biotin binding sites of the immobilized avidin could also account for the lower capacity of the gel to bind insulin. It should be noted that the avidin Sepharose used in this work resulted from a loo-fold dilution of immobilized avidin with inert gel (see under Materials and Methods). Thus, gels having as much as a loo-fold higher capacity to bind biotin can be obtained simply by diluting the immobilized avidin less.
The initial slopes of 0.93 and 0.85 observed for the plots of the amount of Binsulin and BPE-insulin bound versus the amount of insulin derivative added ( Fig.  1) indicate that essentially all of the derivatized insulin was competent to bind to the avidin Sepharose. In the presence of excess avidin Sepharose, binding of biotinoylated insulin proceeded at a reasonable rate. For example, 0.17 nmol of BPEinsulin bound to 0.1 ml of avidin Sepharose (containing 0.89 nmol of sites for BPE-insulin) with a half-time of 8 min. This halftime for binding could be decreased by using gels which contained higher concentrations of immobilized avidin. As the amount of biotinoylated insulin approached the capacity of the avidin Sepharose, the time required to ensure complete reaction (e.g., in the titrations depicted in Fig. 1 ) increased from 1 to 4 h. The decreased rate of binding with increased degree of saturation may well reflect the existence of a population of sterically hindered biotin binding sites which reacts more slowly with biotinoylated insulin.
Previous studies from this laboratory (12, 13) demonstrated that a phenyl ester linkage such as the one in BPE-insulin is readily cleaved at 25°C by treatment with 1 M hydroxylamine at pH 7.0. Figure 1 illustrates the greater than 85% release of BPE-insulin from avidin Sepharose that we obtained upon treatment of the bound BPE-insulin with 1 M hydroxylamine (pH 7.0) for 40 min at room temperature.
However, well over 90% of the releasable BPEinsulin was released within 20 min. The failure to observe quantitative release of the BPE-insulin from the avidin Sepharose appears to be due to nonspecific interactions between the BPE-insulin and the Sepharose. Thus, the inert Sepharose derivative that was used to dilute the immobilized avidin (see under Materials and Methods) exhibited a binding capacity (after incubation of 0.1 ml gel with 2.7 nmol BPE-insulin) which was 1.2 nmol/ml gel. Most of this nonspecifically bound insulin (0.9 nmol/ml gel) was not released by treatment with hydroxylamine. This amount of nonreleasable BPE-insulin accounts for most of the nonreleasable BPEinsulin (1.1 nmol/ml gel) which was observed when 0.1 ml avidin Sepharose was incubated with 2.7 nmol of BPE-insulin and then treated with hydroxylamine ( Fig.  1) . It should be noted that the nonspecific binding of proteins to the inert gel diluent can be minimized by the use of smaller volumes of gels which contain a higher fraction of the immobilized avidin. Several control experiments were performed to verify that binding of BPE-insulin to the avidin Sepharose was dependent on the biotin:avidin interaction and that the subsequent release of bound insulin from the gel was due to hydroxylamine-mediated cleavage of the phenyl ester-containing connector arm. Little binding (~5% of that expected for BPEinsulin) was observed when avidin Sepharose was incubated with excess [lZI]-insulin which had not been treated with BPE. Avidin Sepharose that had been treated with hydroxylamine and then washed with buffer was indistinguishable from untreated avidin Sepharose with respect to its ability to bind biotin or BPEinsulin. Incubation of the avidin Sepharose with biotin prior to treatment of the gel with BPE-insulin resulted in binding which was at the level seen for the nonspecific binding of BPE-insulin to the inert Sepharose diluent. Similarly, when avidin Sepharose was saturated with BPE-insulin and then treated with hydroxylamine to release the bound insulin from the gel, the resulting avidin Sepharose had a capacity for additional BPE-insulin which was less than 10% of that observed for avidin Sepharose which had not been preincubated with BPE-insulin and hydroxylamine.
These results suggest that the pretreatment of the avidin Sepharose with BPE-insulin and hydroxylamine, like the pretreatment of avidin Sepharose with free biotin, saturated the insulin-accessible biotin binding sites on the immobilized avidin, and thereby prevented subsequent binding of BPE-insulin.
In the absence of added hydroxylamine, bound BPE-insulin was not released from avidin Sepharose by extensive washing with neutral buffers at either low or high concentrations of salt. The view that the release of insulin from avidin-bound BPEinsulin is dependent upon hydroxylaminemediated cleavage of the phenyl ester linkage was further substantiated by studies with B-insulin wherein the biotin label is connected to insulin via a connector arm which should not be cleaved by the hydroxylamine treatment. As shown in Fig.  1 , avidin Sepharose bound B-insulin and BPE-insulin similarly. However, less than 2% of the bound B-insulin was released from the avidin Sepharose by the hydroxylamine treatment.
The possibility that the hydroxylamine treatment described in this work could result in chemical modification of protein should be considered. Bornstein and Balbian (2) have shown that treatment of reduced carboxymethylated ribonuclease for 2 h at 45°C with 2 M hydroxylamine in 0.2 M K&O3 at pH 9 resulted only in cleavage at an Asn-Gly bond and 5-10% cleavage at an Asn-Leu bond. It should be noted that this hydroxylamine-mediated cleavage requires hydroxide ion-catalyzed attack of the nitrogen atom of the amide backbone on the /3-carboxamido group of the Asn to displace ammonia and form a cyclic imide. It is this imide intermediate which is then cleaved upon attack by the nucleophile hydroxylamine (1) . Hydroxide ion-catalyzed formation of the imide intermediate should be several hundred times slower at pH 7.0, 25°C than at pH 9.0, 45°C. Thus, hydroxylamine-mediated peptide bond cleavage should not be significant under the conditions used to cleave the phenyl ester linkage. Naturally, one cannot a @ori exclude the possibility that some proteins might contain a bond which is reactive toward hydroxylamine. Should this become a concern, however, one could use a weaker nucleophile such as imidazole to cleave the phenyl ester linkage (12) .
The selective binding of BPE-insulin to avidin and its subseqent release suggests that BPE will enable us to exploit fully the high affinity of avidin for biotin in the design of protocols for selective retrieval of biotinoylated compounds from cells and physiological fluids. In the case of insulin, it is likely that some of the BPE-insulin derivatives will be useful for the isolation and characterization of the insulin receptor, since biotinoylated insulin derivatives are competent to bind the insulin receptor of rat epididymal fat cells and induce insulin-like effects on metabolism ((9), and unpublished observations of this laboratory). A possible limitation of the use of the biotin label (as well as any other probe) is that the label itself might modify the physiological properties of the polypeptide so as to produce "artifactual" behavior. Determination of the behavior of several different polypeptide derivatives should minimize this problem, however.
